Zobrazeno 1 - 10
of 37
pro vyhledávání: '"Agnieszka Jasiecka"'
Publikováno v:
BMC Veterinary Research, Vol 20, Iss 1, Pp 1-12 (2024)
Abstract Background Oclacitinib (OCL), a Janus kinase inhibitor, is a novel immunomodulatory/immunosuppressive agent which is an approved as the first-line treatment for atopic dermatitis (AD) in dogs. The aim of the study was to investigate the effe
Externí odkaz:
https://doaj.org/article/bc592ec83bbc444495d3d8fef458b7eb
Autor:
Hubert Ziółkowski, Agnieszka Jasiecka-Mikołajczyk, Hanna Madej-Śmiechowska, Joanna Janiuk, Aleksandra Zygmuntowicz, Michał Dąbrowski
Publikováno v:
Poultry Science, Vol 99, Iss 10, Pp 4750-4757 (2020)
Tetracyclines continue to be important antimicrobials in veterinary medicine. However, the pharmacokinetics (PK) of tigecycline (TIG) and minocycline (MIN) in broiler chickens has not been investigated to date, and the PK of chlortetracycline (CTC) a
Externí odkaz:
https://doaj.org/article/e9d9a9ca4d0347ff96a050a9d337604b
Autor:
Agnieszka Bęś, Łukasz Sikorski, Tomasz Mikołajczyk, Mateusz Kuczyński, Mateusz Łuba, Bogusław Pierożyński, Agnieszka Jasiecka-Mikołajczyk
Publikováno v:
Applied Sciences, Vol 12, Iss 17, p 8672 (2022)
In this study, we report on the effectiveness of electrochemical and biological wastewater treatment for artificially prepared industrial wastewater, comprising small amounts of technologically important dyes, namely Acid Mixture composed of Acid Vio
Externí odkaz:
https://doaj.org/article/8aa5cf7050fd4562b2269dff4985e09e
Publikováno v:
Molecules, Vol 26, Iss 18, p 5655 (2021)
The purpose of the present study was to broaden the knowledge and understanding of the effects of oclacitinib (OCL), a Janus kinase inhibitor, on T cells in the context of both the immune mechanisms underlying anti-inflammatory and anti-allergic prop
Externí odkaz:
https://doaj.org/article/ead7528daf824316967ea437225bc90b
Autor:
Mateusz Kuczyński, Mateusz Łuba, Tomasz Mikołajczyk, Bogusław Pierożyński, Agnieszka Jasiecka-Mikołajczyk, Lech Smoczyński, Piotr Sołowiej, Paweł Wojtacha
Publikováno v:
Molecules, Vol 26, Iss 15, p 4580 (2021)
Traditional wastewater purification processes are based on a combination of physical, chemical, and biological methods; however, typical electrochemical techniques for removing pollutants require large amounts of electrical energy. In this study, we
Externí odkaz:
https://doaj.org/article/3d7c1bdf8dba4f3bb726cad42f0d25c9
Publikováno v:
Molecules, Vol 26, Iss 11, p 3117 (2021)
The main purpose of this study was to investigate whether the blockade of the interaction between the receptor activator of nuclear factor-κB (NF-ĸB) ligand (RANKL) and its receptor RANK as well as the blockade of NF-κB inhibitor kinase (IKK) and
Externí odkaz:
https://doaj.org/article/f4d5ed488ca7446187a44038465bda84
Autor:
Mateusz Łuba, Tomasz Mikołajczyk, Mateusz Kuczyński, Bogusław Pierożyński, Agnieszka Jasiecka-Mikołajczyk, Bartosz Rasiński, Paweł Wojtacha
Publikováno v:
DESALINATION AND WATER TREATMENT. 287:67-79
Publikováno v:
Research in Veterinary Science. 132:17-27
Teriflunomide (TER) is an immunomodulatory agent. Although the first reports on the use of TER in dogs have already appeared, immune mechanisms underlying the immunomodulatory effect of TER do not seem to have been fully elucidated yet. There were tw
Autor:
Joanna Janiuk, Hubert Ziółkowski, Michał Dąbrowski, Agnieszka Jasiecka-Mikołajczyk, Aleksandra Zygmuntowicz, H Madej-Śmiechowska
Publikováno v:
Poultry Science, Vol 99, Iss 10, Pp 4750-4757 (2020)
Poultry Science
Poultry Science
Tetracyclines continue to be important antimicrobials in veterinary medicine. However, the pharmacokinetics (PK) of tigecycline (TIG) and minocycline (MIN) in broiler chickens has not been investigated to date, and the PK of chlortetracycline (CTC) a
Publikováno v:
Research in Veterinary Science. 121:124-129
Oclacitinib (OCL) is a novel immunosuppressive agent approved for dogs that controls itch and inflammation in allergic disease via the inhibition of the JAK/STAT pathway. This paper investigates the in vitro effect of OCL, a novel Janus kinase inhibi